AVID BIOSERVICES INC's ticker is CDMO and the CUSIP is 05368M106. A total of 173 filers reported holding AVID BIOSERVICES INC in Q2 2024. The put-call ratio across all filers is 5.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,285,219 | -11.2% | 460,159 | -16.6% | 0.00% | 0.0% |
Q1 2024 | $3,698,616 | -22.0% | 552,032 | -24.3% | 0.00% | 0.0% |
Q4 2023 | $4,741,753 | -50.5% | 729,392 | -28.2% | 0.00% | -66.7% |
Q3 2023 | $9,585,329 | -41.9% | 1,015,323 | -14.1% | 0.00% | -40.0% |
Q2 2023 | $16,506,322 | -18.5% | 1,181,661 | +9.5% | 0.01% | -28.6% |
Q1 2023 | $20,246,636 | +151696.6% | 1,079,245 | +11.4% | 0.01% | +75.0% |
Q4 2022 | $13,338 | -99.9% | 968,643 | +23.9% | 0.00% | -33.3% |
Q3 2022 | $14,952,000 | +49.9% | 781,986 | +19.6% | 0.01% | +50.0% |
Q2 2022 | $9,975,000 | -30.3% | 653,660 | -7.0% | 0.00% | 0.0% |
Q1 2022 | $14,313,000 | -35.9% | 702,638 | -8.2% | 0.00% | -42.9% |
Q4 2021 | $22,337,000 | +17.0% | 765,476 | -13.5% | 0.01% | +16.7% |
Q3 2021 | $19,098,000 | -2.7% | 885,379 | +15.7% | 0.01% | 0.0% |
Q2 2021 | $19,627,000 | +172.4% | 765,201 | +93.8% | 0.01% | +200.0% |
Q1 2021 | $7,206,000 | +1069.8% | 394,823 | +640.1% | 0.00% | – |
Q4 2020 | $616,000 | – | 53,348 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
12 West Capital Management LP | 3,645,844 | $26,031,326 | 2.68% |
AltraVue Capital, LLC | 3,395,263 | $24,242,177 | 2.41% |
AYAL Capital Advisors Ltd | 768,662 | $5,488,247 | 2.08% |
Millrace Asset Group, Inc. | 183,464 | $1,310 | 1.27% |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,917,040 | $20,827,669 | 1.22% |
Coliseum Capital Management, LLC | 1,746,588 | $12,470,638 | 1.11% |
Portolan Capital Management | 1,820,779 | $13,000,362 | 1.07% |
272 Capital LP | 264,540 | $1,888,816 | 0.95% |
Sargent Investment Group, LLC | 595,980 | $4,255,297 | 0.87% |
Sapience Investments, LLC | 202,470 | $1,445,636 | 0.74% |